FreeGuest Editorial Immunotherapy, precision medicine in lung cancer drive sharp decline in cancer mortality overall January 08, 2020Vol.46 No.02By Otis W. Brawley
FreeGuest Editorial FDA e-cigarette flavoring ban leaves a bad taste“Trump eroding role of science in government” January 03, 2020Vol.46 No.01By Alan Blum
FDA guidance restricts e-cigarette flavors, leaving tobacco and menthol on the market January 03, 2020Vol.46 No.01By Alexandria Carolan and Matthew Bin Han Ong
Fox Chase acquired by Jefferson in definitive agreement with Temple December 20, 2019Vol.46 No.01By Matthew Bin Han Ong
Trump approves $212.5M increase to improve NCI success rates; FY20 spending bills provide new funding for childhood cancer, raise tobacco-purchase age to 21 December 20, 2019Vol.46 No.01By Alexandria Carolan and Matthew Bin Han Ong
Moffitt CEO Alan List, director Thomas Sellers resign over conflicts of interests involving China December 20, 2019Vol.46 No.01By Matthew Bin Han Ong
Pazdur on the challenge of approving drugs for small indicationsODAC recommends approval for tazemetostat in rare sarcoma, sNDAs for Lynparza, Keytruda December 20, 2019Vol.46 No.01By Paul Goldberg
FreeTrials & Tribulations Nobel Prize Award: Impact of Clinical Care? December 13, 2019Vol.45 No.46By Ilene Sussman
Free Don’t call me Karen, Cheryl, Nancy, Reshma, Cornelia, Caryn, Sharon, … call me “Doctor.” December 13, 2019Vol.45 No.46By Alexandria Carolan
Free “Call me Doctor”How women in oncology are fighting for cultural change December 13, 2019Vol.45 No.46By Alexandria Carolan
